The latest advances in chemotherapy for gastrointestinal cancers

International Journal of Clinical Oncology

Volumn 8, Issue 4, 2003, Pages 234-238

  Ohtsu, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Chemoradiotherapy; Chemotherapy; Endoscopic mucosal resection; Gastrointestinal cancer

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IMATINIB; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; PREDNISOLONE; UFT; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; ENDOSCOPIC SURGERY; ERADICATION THERAPY; ESOPHAGUS CANCER; HELICOBACTER PYLORI; HUMAN; JAPAN; PRIORITY JOURNAL; STOMACH CANCER; STOMACH LYMPHOMA; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; GASTROINTESTINAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0141792166     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-003-0329-5     Document Type: Conference Paper

References (16)

1. Walsh TN, Noonan N, Hollywood D, et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467
2. Al-Sarraf M, Martz K, Herskovic A, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284
3. Minsky BD, Pajak TF, Ginsberg RJ, et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined modality therapy for esophageal cancer: high dose versus standard dose radiation therapy. J Clin Oncol 20:1167-1174
4. Ohtsu A, Boku N, Muro K, et al. (1999) Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915-2921
5. Ohtsu A, Shimada Y, Shirao K, et al. (2003) Randomized phase III trial of 5-fluorouracil alone versus 5-fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin C in patients with unresectable advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG 9205). J Clin Oncol 21:54-59
6. Sakata Y, Ohtsu A, Horikoshi N, et al. (1998) Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur - 0.4 M gimestat - 1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 34:1715-1720
7. Douillard JY, Cunningham D, Roth AD, et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial. Lancet 355:1041-1047
8. Saltz LB, Cox JV, Blanke C, et al. (2000) Irinotecan plus flurorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343:905-914
9. De Gramont A, Figer A, Seymour M, et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947
10. Hoff P, Ansari R, Batist G, et al. (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19: 2282-2292
11. Van Custem E, Twelves C, Cassidy J, et al. (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097-4106
12. Douillard JY, Hoff PM, Skillings JR, et al. (2002) Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3605-3616
13. Carmichael J, Popiela T, Radstone D, et al. (2002) Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3617-3627
14. Wotherspoon AC, Doglioni C, Diss TC, et al. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577
15. Miller TP, Dahlberg S, Casady JR, et al. (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339:21-26
16. Demetri GD, Von Mehren M, Blanke CD, et al. (2002) Efficacy and safety of imatinib mcsylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480